Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.29
+0.54 (8.00%)
At close: Jun 26, 2026, 4:00 PM EDT
7.21
-0.08 (-1.10%)
After-hours: Jun 26, 2026, 6:53 PM EDT
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $188.1 million as of June 26, 2026. Its market cap has increased by 234.59% in one year.
Market Cap
188.10M
Enterprise Value
115.38M
1-Year Change
234.59%
Ranking
Category
Stock Price
$7.29
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $188.10M, a decrease of -78.00%. That is a compound annual growth rate of -18.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 188.10M | 87.84% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediWound | 195.87M |
| Arcturus Therapeutics Holdings | 195.55M |
| Equillium | 192.84M |
| Oramed Pharmaceuticals | 191.12M |
| Unicycive Therapeutics | 190.37M |
| NovaBridge Biosciences | 189.66M |
| AN2 Therapeutics | 187.28M |
| Protalix BioTherapeutics | 185.31M |